BioCardia (BCDA) EBITDA Margin (QoQ) (2012 - 2024)
Powered by 
Analysis
BioCardia (BCDA) EBITDA Margin (QoQ) (2012 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn |
| 10 | BioCardia | 13.06 Mn | 8.94 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | -5.08 Mn |
| Mar 31, 2024 | 1.19 Mn |
| Dec 31, 2023 | -1.53 Mn |
| Sep 30, 2023 | 730,018.00 |
| Jun 30, 2023 | -254,353.00 |
| Mar 31, 2023 | -263,721.00 |
| Dec 31, 2022 | -140,377.00 |
| Sep 30, 2022 | -118,713.00 |
| Jun 30, 2022 | 528,874.00 |
| Mar 31, 2022 | -116,399.00 |
| Dec 31, 2021 | -405,117.00 |
| Sep 30, 2021 | 472,668.00 |
| Jun 30, 2021 | 140,435.00 |
| Mar 31, 2021 | 114,348.00 |
| Dec 31, 2020 | 371,330.00 |
| Sep 30, 2020 | 191,939.00 |
| Jun 30, 2020 | -110,809.00 |
| Mar 31, 2020 | -1.05 Mn |
| Dec 31, 2019 | 1,922.00 |
| Sep 30, 2019 | 271,102.00 |